There is no commercial support for this activity.

About the speakers

Millie Sweeney, M.S., is the Deputy Director for the Family-Run Executive Director Leadership Association (FREDLA).  Spanning the children’s mental health and child-serving systems, she has over twenty years’ direct experience in navigating systems with and on behalf of families, advocating at both the individual and policy level, and building collaborations with professionals and systems.  For twelve years, she operated as a member of the management team within a large statewide family organization, participating in the administration of six system of care sites, supporting the development of the statewide Youth MOVE chapter, and managing up to twenty local and statewide programs. She operated Family Solutions Consulting, focusing on consulting in program development, parent peer support and family driven care nationally before joining the Family-Run Executive Director Leadership Association (FREDLA).  First as Project Coordinator and now as Deputy Director, she specializes in grant and program development, staff supervision and training, parent peer support and family engagement, curriculum development, and systems of care.

Dr. Christopher Bellonci brings 25+ years of experience as a Board Certified Child, Adolescent and Adult Psychiatrist working directly with children and families in outpatient, inpatient and residential settings. He has consulted with state and federal child welfare and mental health agencies helping those agencies develop best practices and service systems to identify, prevent, treat and support children with behavioral health needs and their families. His expertise has led to Congressional testimony and recently advising the Senate Finance Committee regarding the Family First Prevention Services Act. 

Dr. Bellonci is a leader in the field of children’s mental health best practices. He serves on the American Academy of Child and Adolescent Psychiatry’s (AACAP) Quality Issues Committee responsible for developing the field’s clinical practice guidelines defining best practices in treating behavioral health conditions. He also serves on AACAP’s Community-based Systems of Care Committee. 

Dr. Bellonci is an Adjunct Associate Professor at Tufts University School of Medicine and Vice President of Policy and Practice/Chief Medical Officer at Judge Baker Children’s Center. He has several research initiatives underway including a practice parameter on deprescribing in child psychiatry and a systematic review of polypharmacy trials for children.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Christopher Bellonci, MD, reports that he has no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months. He will not discuss any products, services, or off-label uses in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on June 5, 2024. All conflicts have been mitigated through review.

Millie Sweeney, MS, reports that she has no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months. She will not discuss any products, services, or off-label uses in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on June 5, 2024. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.